Artiva Biotherapeutics ARTV
NASDAQ ARTV
$7.12 +0.09 (+1.28%)
At close: Sep 30, 2026 · 4:00 PM EDT

Artiva Biotherapeutics (ARTV) Minority Interest (2023 - 2024)

Updated

Artiva Biotherapeutics' Minority Interest came in at $216.41 million for Q2 2024.

Analysis

Artiva Biotherapeutics (ARTV) Minority Interest (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Artiva Biotherapeutics 280.62 Mn 280.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 216.41 Mn
Dec 31, 2023 216.41 Mn
API Access

Artiva Biotherapeutics Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=ARTV&period=max&api_key=YOUR_API_KEY